- Home
- BMRN vs W Comparison
BMRN vs W Comparison
Compare BMRN & W Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- W
- Stock Information
- Founded
- BMRN 1996
- W 2002
- Country
- BMRN United States
- W United States
- Employees
- BMRN N/A
- W N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- W Catalog/Specialty Distribution
- Sector
- BMRN Health Care
- W Consumer Discretionary
- Exchange
- BMRN Nasdaq
- W Nasdaq
- Market Cap
- BMRN 10.0B
- W 8.4B
- IPO Year
- BMRN 1999
- W 2014
- Fundamental
- Price
- BMRN $52.47
- W $79.17
- Analyst Decision
- BMRN Buy
- W Buy
- Analyst Count
- BMRN 18
- W 25
- Target Price
- BMRN $93.71
- W $72.52
- AVG Volume (30 Days)
- BMRN 2.2M
- W 3.3M
- Earning Date
- BMRN 10-28-2025
- W 10-28-2025
- Dividend Yield
- BMRN N/A
- W N/A
- EPS Growth
- BMRN 154.69
- W N/A
- EPS
- BMRN 3.40
- W N/A
- Revenue
- BMRN $3,063,608,000.00
- W $12,008,000,000.00
- Revenue This Year
- BMRN $13.35
- W $5.27
- Revenue Next Year
- BMRN $9.18
- W $4.04
- P/E Ratio
- BMRN $15.44
- W N/A
- Revenue Growth
- BMRN 18.36
- W 0.87
- 52 Week Low
- BMRN $51.57
- W $20.41
- 52 Week High
- BMRN $73.51
- W $91.77
- Technical
- Relative Strength Index (RSI)
- BMRN 38.26
- W 46.17
- Support Level
- BMRN $51.79
- W $83.84
- Resistance Level
- BMRN $55.39
- W $90.52
- Average True Range (ATR)
- BMRN 1.36
- W 4.30
- MACD
- BMRN -0.11
- W -1.66
- Stochastic Oscillator
- BMRN 19.28
- W 32.40
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About W Wayfair Inc.
Wayfair engages in e-commerce in the United States (88% of 2024 sales), Canada, the United Kingdom, and Ireland. It's also embarked on expansion into the brick-and-mortar landscape, with a handful of stores between the AllModern, Birch Lane, Joss & Main, and Wayfair banners. At the end of 2024, the firm offered more than 30 million products from more than 20,000 suppliers under the brands Wayfair, Joss & Main, AllModern, Birch Lane, and Perigold. Its offerings include furniture, everyday and seasonal decor, decorative accents, housewares, and other home goods. Wayfair was founded in 2002 and began trading publicly in 2014.